Gene therapy: Began Phase I trial

Viagene Inc. (VIGN), San Diego Product: Gene therapy using envelope gene from HIV to trigger cytotoxic T lymphocytes to destroy cells infected with HIV Indication: HIV infection Status: Began Phase I ...